Please login to the form below

Not currently logged in
Email:
Password:

Ferring appoints executive VP and chief medical officer

Professor Klaus Dugi joins the pharma group from Boehringer Ingelheim

Klaus DugiFerring Pharmaceuticals has appointed professor Klaus Dugi as its executive vice president and chief medical officer; roles that will see him take the helm of its global medical affairs, quality assurance and pharmacovigilance business.

Prior to his new role, Professor Dugi has held various leadership roles at Boehringer Ingelheim, including vice president, global affairs, chief medical officer, and most recently managing director UK and Ireland.

Michel Pettigrew, president of the executive board and chief operating officer, Ferring Pharmaceuticals, said: “Making the industry more patient-centric has always been a top priory for Professor Dugi, and this is perfectly aligned with our company philosophy and commitment so solving unmet patient needs, particularly in the area of reproductive and maternal health.”

Additionally, Professor Dugi will also be a member of the Swiss group’s medical board, effective immediately.

12th October 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics